• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Medroxyprogesterone acetate in human serum.

作者信息

Mathrubutham M, Fotherby K

出版信息

J Steroid Biochem. 1981 Aug;14(8):783-6. doi: 10.1016/0022-4731(81)90015-7.

DOI:10.1016/0022-4731(81)90015-7
PMID:6457936
Abstract
摘要

相似文献

1
Medroxyprogesterone acetate in human serum.人血清中的醋酸甲羟孕酮。
J Steroid Biochem. 1981 Aug;14(8):783-6. doi: 10.1016/0022-4731(81)90015-7.
2
Radioimmunoassay of serum medroxyprogesterone acetate (Provera) in women following oral and intravaginal administration.口服和阴道内给药后女性血清醋酸甲羟孕酮（安宫黄体酮）的放射免疫测定
Steroids. 1975 Sep;26(3):373-86. doi: 10.1016/0039-128x(75)90082-3.
3
Radioimmunoassay for medroxyprogesterone acetate (Provera) using the 11alpha-hydroxy succinyl conjugate.
Steroids. 1974 May;23(5):713-30. doi: 10.1016/0039-128x(74)90160-3.
4
A radioimmunoassay for serum medroxyprogesterone acetate.血清醋酸甲羟孕酮的放射免疫测定法。
J Steroid Biochem. 1978 Apr;9(4):359-63. doi: 10.1016/0022-4731(78)90631-3.
5
Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera) as a contraceptive agent.长期使用醋酸甲羟孕酮（Depo - Provera，一种避孕药物）的女性体内醋酸甲羟孕酮（MPA）、性激素结合球蛋白、性腺甾体激素、促性腺激素及催乳素的血浆水平。
Acta Endocrinol (Copenh). 1982 Mar;99(3):339-43. doi: 10.1530/acta.0.0990339.
6
Binding of the contraceptive steroids medroxyprogesterone acetate and ethynyloestradiol in blood of various species.
J Steroid Biochem. 1981 May;14(5):493-8. doi: 10.1016/0022-4731(81)90362-9.
7
Radioimmunoassay for serum medroxyprogesterone acetate in Thai women receiving injectable DMPA contraceptive.泰国接受醋酸甲羟孕酮注射避孕的女性血清中醋酸甲羟孕酮的放射免疫测定法。
Contraception. 1979 Oct;20(4):319-27. doi: 10.1016/s0010-7824(79)80042-6.
8
Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of depo-MPA.肌肉注射醋酸甲羟孕酮长效避孕针后血清醋酸甲羟孕酮（MPA）浓度及卵巢功能
J Clin Endocrinol Metab. 1977 Jan;44(1):32-8. doi: 10.1210/jcem-44-1-32.
9
Plasma medroxyprogesterone acetate levels following intramuscular or oral administration in patients with endometrial adenocarcinoma.子宫内膜腺癌患者肌内注射或口服醋酸甲羟孕酮后的血浆水平。
Acta Obstet Gynecol Scand. 1979;58(1):95-9. doi: 10.3109/00016347909154923.
10
Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.肠道细菌在合成及天然甾体激素代谢中作用的研究。
J Steroid Biochem. 1984 Jan;20(1):217-29. doi: 10.1016/0022-4731(84)90208-5.

引用本文的文献

1
Variability and quantification of serum medroxyprogesterone acetate levels.血清醋酸甲羟孕酮水平的变异性和定量。
Steroids. 2022 Nov;187:109100. doi: 10.1016/j.steroids.2022.109100. Epub 2022 Aug 12.
2
Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms.激素避孕与 HIV-1 感染：生物学机制。
Endocr Rev. 2018 Feb 1;39(1):36-78. doi: 10.1210/er.2017-00103.
3
Is a lower-dose, subcutaneous contraceptive injectable containing depot medroxyprogesterone acetate likely to impact women's risk of HIV?一种含有醋酸甲羟孕酮长效注射剂的低剂量皮下避孕针剂是否可能影响女性感染艾滋病毒的风险？
Contraception. 2018 Mar;97(3):191-197. doi: 10.1016/j.contraception.2017.12.003. Epub 2017 Dec 11.
4
The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells.醋酸甲羟孕酮的孕激素和雄激素特性：与双氢睾酮在乳腺癌细胞中的基因调控重叠
Breast Cancer Res. 2005;7(6):R1036-50. doi: 10.1186/bcr1340. Epub 2005 Nov 2.
5
Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception.用于激素替代疗法和避孕的孕激素的药代动力学及效能。
Rev Endocr Metab Disord. 2002 Sep;3(3):211-24. doi: 10.1023/a:1020072325818.
6
Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions.利用体外和体内数据评估代谢性药代动力学相互作用的可能性。
Clin Pharmacokinet. 1997 Mar;32(3):210-58. doi: 10.2165/00003088-199732030-00004.
7
An evaluation of high-dose medroxyprogesterone acetate (MPA) therapy in women with advanced breast cancer.对晚期乳腺癌女性患者进行大剂量醋酸甲羟孕酮（MPA）治疗的评估。
Br J Cancer. 1984 Sep;50(3):363-6. doi: 10.1038/bjc.1984.184.
8
Plasma concentrations of medroxyprogesterone acetate and megesterol acetate during long-term follow-up in patients treated for metastatic breast cancer.转移性乳腺癌患者长期随访期间醋酸甲羟孕酮和醋酸甲地孕酮的血浆浓度。
J Cancer Res Clin Oncol. 1988;114(2):186-90. doi: 10.1007/BF00417835.
9
Effect of oral high-dose progestins on the disposition of antipyrine, digitoxin, and warfarin in patients with advanced breast cancer.
Cancer Chemother Pharmacol. 1986;18(3):270-5. doi: 10.1007/BF00273401.
10
Clinical significance of differences in bioavailability of medroxyprogesterone acetate preparations.醋酸甲羟孕酮制剂生物利用度差异的临床意义
Clin Pharmacokinet. 1989 Mar;16(3):129-33. doi: 10.2165/00003088-198916030-00001.